Organic Chemistry TRIZ Cases

Explore fluorine-containing compounds that reduce surface tension and enhance interface activity without perfluoroalkyl groups.

Nitrogen-containing detergents help prevent particulate buildup and improve filterability in renewable diesel and biodiesel blends.

Integrated acid generation and quenching in a bis-onium salt limits diffusion while preserving EUV sensitivity, LWR, and CDU.

Buffered oxidation supports acid-labile compounds while improving ketone yield and purity.

This case uses Formula I compounds to improve p300/CBP HAT potency and specificity while limiting off-target effects.

This case combines aromatic readthrough compounds with aminoglycosides to improve premature stop codon readthrough and limit toxicity.

This case uses azaspiro small molecules to inhibit WRN activity and address resistance in cancers linked to WRN mutations.

X4P-001 uses isolated intermediates and selective purification to limit impurities in CXCR4 inhibitor compositions.

This case uses thiol-based SAM layers and NTA chelation to limit dissociation and flow-cell drift in SPR/LSPR protein analysis.

This case develops fluorine-containing ether compounds without CF3 or CF2 groups, broadening structures for solvent and industrial use.

Alternating organic and inorganic encapsulation films filter UV and visible light, improving light-emitting device reliability.

An optimized capping-layer refractive index improves OLED light extraction, color purity, lifespan, and low-voltage operation.

Phenylcarbazole compounds tune OLED layers for resonance and brighter, purer light.

pH-responsive ionizable lipids encapsulate large saRNA, reduce nonspecific interactions, and support endosomal escape.

This case uses glycidyl compounds with reversible Diels-Alder bonding to retain cured strength while enabling remolding and reuse.

Formula I compounds selectively inhibit CDK4 to preserve anti-cancer activity while improving tolerability and treatment continuity.

A phthalimide core, linker, and variable warhead support CRBN binding and degradation of IKZF1/3, WEE1, and GSPT1.

Rb1 modulators reshape the tumor microenvironment to improve immunotherapy response and reduce pancreatic tumor burden.

CAP-C uses UV-activated dendrimers to capture genomic proximity without masking restriction sites.

Modified capsaicin linkages increase hydrophobicity and control hydrolysis, supporting dermal uptake with less irritation.

A hydroxyphosphate catalyst converts methanol, ethanol, and acetone into methylphenol homologues with improved selectivity and separation.

Controlled cooling after oxidation yields 20–500 micron ACFC crystals with low color and purity for direct polymer use.

A controlled amino acid composite reaches high aspect ratio and gas barrier performance while keeping yellowness low.

This case uses acidic solid supports for solvent-free CBD-to-THC conversion, shorter reaction times, and tunable THC-8/THC-9 ratios.

A chemically amplified resist uses acid-triggered solubility change to form fine patterns with improved roughness and etching resistance.

Formula D0 resist chemistry balances high-resolution immersion patterning with lower substance elution and defect occurrence.

NPO-pyr uses fluorescence turn-on to detect homocysteine in plasma, supporting earlier glioblastoma diagnosis without complex testing.

Chromanone compounds selectively target myeloma cells while sparing normal stem cells.

The case uses an E3 ligase-binding PROTAC to degrade PARP-1, reducing protein trapping and addressing resistance and blood toxicity.

Specific acid dissociation and C Log P ranges balance acid quenching with dissolution contrast for low-LWR resist patterns.

Amide methylation and ortho substitution improve Nav1.7 selectivity over Nav1.5 for more targeted pain treatment.

This case uses substituted norbornyl RXFP1 agonists to activate relaxin signaling, improve renal function, and reduce fibrosis.

Controlled crystallization of Rucaparib Tosylate forms improves stability, dissolution, and pharmaceutical handling.

Systematic pinane isomer mixtures provide distinct woody, pine-like, and other notes with high substantivity and stability.

Covalently immobilized sulfonephthalein dyes preserve spectral response and resist humidity and immersion degradation in water-quality pads.

This case introduces fluorinated aromatic compounds that improve electron transport, luminous efficiency, and OLED lifespan.

This case develops orally bioavailable αvβ6 integrin inhibitors to improve patient compliance while preserving selective therapeutic action.

This case varies DGK inhibitor structures to improve therapeutic efficacy for cancer and viral infection treatment.

This case uses a higher-boiling organic solvent during distillation to reduce un-sulfurized phenol and metal salt residues below 0.3 wt%.

After resin regeneration, methanol washing raises effluent pH to protect titanium zeolite catalyst during propene epoxidation.

This case uses a hydroxyl-bearing mediator and multicopper oxidase to produce phenylacetaldehyde in mild, food-compatible conditions.

Phenylacrylonitrile compounds in polymer films provide blue-violet filtration, thermal stability, and wavelength-graded transmittance.

Non-polymeric fluorescent films use quenching under UV irradiation for rapid, portable vapor-phase narcotic detection.

Modular porous networks accommodate medium-sized molecules for crystal structure analysis.

This case combines hydroxymethylation and epoxidation in one pot to produce BFFE with high monomeric yield and lower process complexity.

The combination targets residual cardiovascular risk after acute coronary syndrome and can reduce MACE by up to 70%.

Oral ER antagonists target brain metastases by crossing the blood-brain barrier.

This case uses mJJ64A to selectively activate Akt3, increasing Foxp3 expression, Treg activity, and anti-inflammatory cytokine secretion.

This case uses basic solvent extraction and pH adjustment to produce methylene blue above 97% purity and below 77 ppm total metals.

This OLED case combines Formula-based host compounds with a TADF emitter to limit exciton leakage, sustain brightness, and extend lifespan.

Inverted donor-centered TADF molecules with 40-90 degree torsion angles resolve the trade-off between emission decay time and brightness in OLEDs.

Amino acid nitrate compositions resolve slow vasodilation and poor bioavailability by merging amino acids with nitrates to form composite compounds.

Structural tuning of quinoline cores balances potency against toxicity to treat tumors safely.

Ruthenium on carbon support and acidic cation exchanger convert trans-isomers to cis-rose oxide, resolving diastereomer separation bottlenecks.

A two-step synthesis method for pyrazolinone salts uses azeotropic dehydration with alkali metal hydroxide and hydrocarbon solvent to produce high-purity active ingredients.

Alkoxylated amine collectors resist hydrolysis at high pH and temperature, reducing acid-insoluble material and improving yield.

A phase-transition optical isomer compound enables selective deposition of a second electrode in transparent electroluminescent displays.

Pyridazinone compounds bind non-canonical G-quadruplex structures to inhibit N-Myc expression in cancer cells.

Replacing anhydride reagents with trifluoroacetic acid eliminates carboxylic acid by-products while maintaining high yield in pest control agent synthesis.

Melt-blended copolycarbonate composition with transesterification catalyst resolves immiscibility between high and low Tg polymers, achieving optical clarity.

Rigid thiophene spacers prevent dipolar aggregation, enabling high macroscopic nonlinearity without stability loss.

Acidic slurry processing converts waste polysaccharides into high-energy-density polymeric solid fuel.

Composite host materials stabilize phosphorescent dopants to extend luminance decay time in organic electroluminescent devices.

UiO-66-X metal-organic framework reacts epoxides with carbon dioxide to form substituted oxazolidinones.

Conjugating a cannabinoid scaffold to a second therapeutic agent resolves the contradiction between metabolic efficacy and neuropsychiatric side effects.

Substituted quinazoline compounds activate glucocerebrosidase via allosteric binding, overcoming the failure of active-site targeting chaperones.

Substituted fatty acids reverse histological changes in non-alcoholic steatohepatitis by lowering bile acid excretion.

Benzotriazine and quinoxaline compounds achieve selective p70S6 kinase inhibition to reduce tumor proliferation while minimizing side effects.

A pH-responsive fluorescent false neurotransmitter accumulates within synaptic vesicles via vesicular monoamine transporters to enable optical detection.

Reflux crystallization in water and acetone produces pure Rivaroxaban Modification I, eliminating column chromatography waste.

Chromanol compounds mitigate oxidative stress and prevent kidney dysfunction by reducing systemic inflammation.

Triazolopurine compounds inhibit xanthine oxidase via competitive binding, reducing skin disorders and liver toxicity associated with allopurinol.

Novel fused thiazole or oxazole compound reduces driving voltage and improves lifetime characteristics in organic light emitting devices.

Packaging solution deposits hydrophilic polymers onto silicone contact lenses to prevent lipid and protein adsorption during extended wear.

Specific chemical compounds inhibit Aurora kinase enzymes, arresting unregulated cell proliferation and promoting apoptosis to treat cancer.

Bisulfite adduct monomers enable room temperature crosslinking while eliminating hazardous formaldehyde release from polymer dispersions.

Addition reaction with dihydropyran forms acetal end-groups that prevent hydroxyl reactivity, eliminating incomplete methylation and hazardous by-products.

Methide anion photoacid generator improves miscibility and reduces acid diffusion to resolve non-uniform distribution defects.

A compound with efficient electron blocking and hole transport abilities optimizes energy levels in organic electric elements.

Composite lipids with targeting moieties localize nucleic acid cargo to immune cells, resolving the trade-off between broad protection and precise delivery.

Fluorinated cyclic carbonate additives form stable solid electrolyte interphases that prevent graphite exfoliation and enable high-voltage operation.

Synthesizing SSZ-120 molecular sieve using naphthalene bisimidazolium dications to achieve high surface area.

A hybrid pyrrolidinone-acetamide molecule targets viral proteases with high affinity.

A pyrene-pyridine fused compound reduces non-radiative decay in organic light-emitting diodes.

GPR40 agonists stimulate pancreatic beta cells to release insulin through receptor activation.

A quaternary ammonium salt additive prevents internal diesel injector deposits and external fouling through surface-active adsorption.

Novel imide compound serves as an acid generator in chemically amplified resist compositions.

Cyclic carbodiimide compounds seal polymer acid groups without releasing isocyanate byproducts.

An iridium complex guest paired with a metal complex host in the emission layer enhances exciton transfer.

Alkylhydrazide crosslinking agents react with polyvinyl alcohol carbonyl groups, preventing time-dependent discoloration while maintaining viscosity stability.

Continuous light irradiation in a flow reactor controls bromination, eliminating carbon tetrachloride and reducing dibromo by-products.

Specific organic compounds optimize energy bandgaps to enhance electron and hole transport in OLED devices.

A meta-connected indolocarbazole compound structure separates HOMO and LUMO orbitals to boost external quantum efficiency.